Hogg Karen, Thomas Jerry, Ashford David, Cartwright Jared, Coldwell Ruth, Weston Daniel J, Pillmoor John, Surry Dominic, O'Toole Peter
Bioscience Technology Facility, Department of Biology, University of York, York YO10 5DD, UK.
AstraZeneca R&D Alderley Park, Alderley Park, Cheshire, SK10 4TG, UK.
Methods. 2015 Jul 1;82:38-46. doi: 10.1016/j.ymeth.2015.03.030. Epub 2015 Apr 24.
Flow cytometry is a powerful tool for the quantitation of fluorescence and is proven to be able to correlate the fluorescence intensity to the number of protein on cells surface. Mass spectroscopy can also be used to determine the number of proteins per cell. Here we have developed two methods, using flow cytometry and mass spectroscopy to quantify number of transporters in human cells. These two approaches were then used to analyse the same samples so that a direct comparison could be made. Transporters have a major impact on the behaviour of a diverse number of drugs in human systems. While active uptake studies by transmembrane protein transporters using model substrates are routinely undertaken in human cell lines and hepatocytes as part of drug discovery and development, the interpretation of these results is currently limited by the inability to quantify the number of transporters present in the test samples. Here we provide a flow cytometric method for accurate quantification of transporter levels both on the cell surface and within the cell, and compare this to a quantitative mass spectrometric approach. Two transporters were selected for the study: OATP1B1 (also known as SLCO1B1, LST-1, OATP-C, OATP2) due to its important role in hepatic drug uptake and elimination; P-gp (also known as P-glycoprotein, MDR1, ABCB1) as a well characterised system and due to its potential impact on oral bioavailability, biliary and renal clearance, and brain penetration of drugs that are substrates for this transporter. In all cases the mass spectrometric method gave higher levels than the flow cytometry method. However, the two methods showed very similar trends in the relative ratios of both transporters in the hepatocyte samples investigated. The P-gp antibody allowed quantitative discrimination between externally facing transporters located in the cytoplasmic membrane and the total number of transporters on and in the cell. The proportion of externally facing transporter varied considerably in the four hepatocyte samples analysed, ranging from only 6% to 35% of intact and viable cells. The sample with only 6% externally facing transporter was further analysed by confocal microscopy which qualitatively confirmed the low level of transporter in the membrane and the large internal population. Here we prove that flow cytometry is an important tool for future protein analysis as it can not only quantify the number of proteins that a cell express but also identify the number of proteins on the surface and it is easy to apply for routine assays.
流式细胞术是一种用于荧光定量的强大工具,并且已被证明能够将荧光强度与细胞表面蛋白质的数量相关联。质谱分析也可用于确定每个细胞中蛋白质的数量。在这里,我们开发了两种方法,利用流式细胞术和质谱分析来定量人类细胞中的转运蛋白数量。然后使用这两种方法分析相同的样本,以便进行直接比较。转运蛋白对多种药物在人体系统中的行为有重大影响。虽然作为药物发现和开发的一部分,使用模型底物通过跨膜蛋白转运体进行的主动摄取研究通常在人类细胞系和肝细胞中进行,但目前这些结果的解释受到无法量化测试样品中存在的转运蛋白数量的限制。在这里,我们提供了一种流式细胞术方法,用于准确量化细胞表面和细胞内的转运蛋白水平,并将其与定量质谱方法进行比较。选择了两种转运蛋白进行研究:OATP1B1(也称为SLCO1B1、LST-1、OATP-C、OATP2),因其在肝脏药物摄取和消除中的重要作用;P-糖蛋白(也称为P-糖蛋白、MDR1、ABCB1),作为一个特征明确的系统,并且由于其对口服生物利用度、胆汁和肾脏清除率以及作为该转运体底物的药物的脑渗透率的潜在影响。在所有情况下,质谱方法给出的水平都高于流式细胞术方法。然而,在研究的肝细胞样本中,两种方法在两种转运蛋白的相对比例上显示出非常相似的趋势。P-糖蛋白抗体能够对位于细胞质膜上的外向转运蛋白与细胞上和细胞内的转运蛋白总数进行定量区分。在分析的四个肝细胞样本中,外向转运蛋白的比例差异很大,范围从完整且有活力的细胞的仅6%到35%。对仅有6%外向转运蛋白的样本通过共聚焦显微镜进行了进一步分析,定性地证实了膜中转运蛋白水平较低且细胞内数量较多。在这里,我们证明流式细胞术是未来蛋白质分析的重要工具,因为它不仅可以量化细胞表达的蛋白质数量,还可以识别表面蛋白质的数量,并且易于应用于常规检测。